Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression

Pain

Volumn 108, Issue 1-2, 2004, Pages 67-75

  Brack, Alexander ^a   Rittner, Heike L ^a   Machelska, Halina ^a   Shaqura, Mohammed ^a   Mousa, Shaaban A ^a   Labuz, Dominika ^a   Zöllner, Christian ^a   Schäfer, Michael ^a   Stein, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemokine; Freund's complete adjuvant; Opioid receptors; PMN; endorphin

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; FREUND ADJUVANT; MACROPHAGE INFLAMMATORY PROTEIN 2; METENKEPHALIN; OPIATE; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE COUNT; MALE; NONHUMAN; PAIN THRESHOLD; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION;

EID: 1342279408     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.12.008     Document Type: Article

References (43)

1. Antonijevic I., Mousa S.A., Schäfer M., Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci. 15:1995;165-172.
2. Blackwell T.S., Lancaster L.H., Blackwell T.R., Venkatakrishnan A., Christman J.W. Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am J Respir Crit Care Med. 159:1999;1644-1652.
3. Bourgoin S., Le Bars D., Clot A.M., Hamon M., Cesselin F. Subcutaneous formalin induces a segmental relase of Met-enkephalin-like material from the spinal cord. Pain. 41:1990;323-329.
4. Buzas B., Cox B.M. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polyme rase chain reaction. Neuroscience. 76:1997;479-489.
5. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schäfer M., Loeffler J.P., Stein C. Immune cell-derived β-endorphin-production, release and control of inflammatory pain in rats. J Clin Invest. 100:1997;142-148.
6. Crisp T., Stafinsky J.L., Hoskins D.L., Perni V.C., Uram M., Gordon T.L. Age related changes in the spinal antinociceptive effects of DAGO, DPDPE and beta-endorphin in the rat. Brain Res. 643:1994;282-286.
7. Cunha F.Q., Lorenzetti B.B., Poole S., Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 104:1991;765-767.
8. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 107:1992;660-664.
9. Frevert C.W., Farone A., Danaee H., Paulauskis J.D., Kobzik L. Functional characterization of rat chemokine macrophage inflammatory protein-2. Inflammation. 19:1995;133-142.
10. Hassan A.H., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55:1993;185-195.
11. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature. 413:2001;203-210.
12. Lorenzetti B.B., Veiga F.H., Canetti C.A., Poole S., Cunha F.Q., Ferreira S.H. CINC-1 mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats. Eur Cytokine Netw. 13:2002;456-461.
13. Machelska H., Cabot P.J., Mousa S.A., Zhang Q., Stein C. Pain control in inflammation governed by selectins. Nat Med. 4:1998;1425-1428.
14. Machelska H., Mousa S.A., Brack A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci. 22:2002;5588-5596.
15. McColl S.R., Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol. 163:1999;2829-2835.
16. Mercer-Jones M.A., Shrotri M.S., Heinzelmann M., Peyton J.C., Cheadle W.G. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J Leukoc Biol. 65:1999;249-255.
17. Mousa S.A., Zhang Q., Sitte N., Ji R., Stein C. Beta-endorphin- containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol. 115:2001;71-78.
18. Mousa S.A., Machelska H., Schäfer M., Stein C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol. 126:2002;5-15.
19. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci. 21:2001;5027-5035.
20. Pol O., Alameda F., Puig M.M. Inflammation enhances mu-opioid receptor transcription and expression in mice intestine. Mol Pharmacol. 60:2001;894-899.
21. Pol O., Valle L., Puig M.M. Antisense oligodeoxynucleotides to mu- and delta-opioid receptor mRNA block the enhanced effects of opioids during intestinal inflammation. Eur J Pharmacol. 428:2001;127-136.
22. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience. 48:1992;491-500.
23. Puig M.M., Pol O. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice. J Pharmacol Exp Ther. 287:1998;1068-1075.
24. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., Stein C. Opioid peptide expressing leukocytes - identification, recruitment and simultaneously increasing inhibiton of inflammatory pain. Anesthesiology. 95:2001;500-508.
25. Rittner H.L., Brack A., Stein C. Pro- versus analgesic actions of immune cells. Curr Opin Anaesthesiol. 16:2003;527-533.
26. Schäfer M., Carter L., Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA. 91:1994;4219-4223.
27. Schäfer M., Imai Y., Uhl G.R., Stein C. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol. 279:1995;165-169.
28. Schäfer M., Mousa S.A., Zhang Q., Carter L., Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA. 93:1996;6096-6100.
29. Schmal H., Shanley T.P., Jones M.L., Friedl H.P., Ward P.A. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol. 156:1996;1963-1972.
30. Scholz J., Woolf C.J. Can we conquer pain? Nat Neurosci. 5:2002;1062-1067.
31. Shaqura M.A., Zöllner C., Mousa S.A., Stein C., Schäfer M. Characterization of μ opioid receptor binding and G-protein coupling in rat hypothalamus, spinal cord and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther. Oct 30:2003;. Epub ahead of print.
32. Shibata F., Konishi K., Kato H., Komorita N., al-Mokdad M., Fujioka M., Nakagawa H. Recombinant production and biological properties of rat cytokine-induced neutrophil chemoattractants, GRO/CINC-2 alpha, CINC-2 beta and CINC-3. Eur J Biochem. 231:1995;306-311.
33. Stein C., Gramsch C., Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci. 10:1990;1292-1298.
34. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA. 87:1990;5935-5939.
35. Stein C., Hassan A.H., Lehrberger K., Giefing J., Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet. 342:1993;321-324.
36. Stein C., Schäfer M., Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med. 9:2003;1003-1008.
37. Takemori A.E., Portoghese P.S. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. Eur J Pharmacol. 242:1993;145-150.
38. Watkins L.R., Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 82:2002;981-1011.
39. Wiekowski M.T., Chen S.C., Zalamea P., Wilburn B.P., Kinsley D.J., Sharif W.W., Jensen K.K., Hedrick J.A., Manfra D., Lira S.A. Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J Immunol. 167:2001;7102-7110.
40. Xu Y., Gu Y., Wu P., Li G.W., Huang L.Y. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum Gene Ther. 14:2003;897-906.
41. Xu Y., Gu Y., Xu G.Y., Wu P., Li G.W., Huang L.Y. Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception. Proc Natl Acad Sci USA. 100:2003;6204-6209.
42. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.
43. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S., Stein C., Schäfer M. Painful inflammation-induced increase in μ-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol. 64:2003;202-210.